Reveleer Names Dr. Jean-Luc Neptune CMO to Steer Clinical AI Strategy
Glendale, Calif. – October 15, 2026 -- Reveleer has appointed Jean-Luc ("JL") Neptune, MD, MBA, as Chief Medical Officer to lead clinical strategy across risk adjustment, quality, and member management programs serving 12 million covered lives.
Neptune will set clinical direction for Reveleer products and shape the company's approach to AI, value-based care, and health care payment reform. He brings more than 20 years of experience putting new technology in front of clinicians at the point of care, first as a physician and later as a digital health founder.
Reveleer cites a gap between AI adoption and operational readiness
Citing its own 2026 State of Technology in Value-Based Care report, Reveleer says AI adoption has outpaced operational readiness. Health plans, it argues, need AI that scales quickly and remains transparent enough to trust.